1. 現在已經有四個被FDA批準上市的 Prolia的biosimilar 藥物 (類似generic,但因為Prolia是生物製藥，所以叫biosimilar)。我下麵列了出來。第一個藥Jubbonti應該今年五月份開始有藥，其他的三個也應該在今年有藥。您去問問醫生可不可以開這個藥，價格優惠多少。
Jubbonti (denosumab-bbdz): Approved by the FDA in March 2024, this is a biosimilar to Prolia.
Ospomyv (denosumab-dssb): Approved by the FDA in February 2025.
Stoboclo (denosumab-bmwo): Approved by the FDA in March 2025.
Conexxence (denosumab-bnht): Approved by the FDA in March 2025.
2. Prolia的製藥廠有病人資助項目，叫做AmgenSupport+, 我把鏈接貼在下麵，您看看能不能申請藥廠資助copay.
https://www.proliahcp.com/support-and-access/access-overview
